logo


Advanced Medical Optics, Inc. Announces Increase in Total Consideration and Extension of Consent Deadline in Tender Offer and Consent Solicitation for Its 7½% Senior Subordinated Notes Due 2017
Monday, February 09, 2009 8:27 PM


Advanced Medical Optics, Inc. (AMO) [NYSE:EYE], announced today that, in connection with its previously announced cash tender offer for its outstanding 7½% Senior Subordinated Notes due 2017 (the “Notes”) (CUSIP No. 00763MAN8, ISIN No. US00763MAN83) and the related consent solicitation to amend the indenture governing the Notes, it has amended the offer to increase the Total Consideration and extend the Consent Deadline (as such terms are defined in the Offer to Purchase and Consent Solicitation Statement dated Jan. 27, 2009 (the “Offer to Purchase”) and the related Letter of Transmittal and Consent).

The expiration time of the tender offer remains midnight EST on Tuesday, Feb. 24, 2009, unless extended or earlier terminated (the “Expiration Time”). The new Consent Deadline is midnight EST on Feb. 24, 2009, the same time as the Expiration Time, unless further extended or earlier terminated.

The Total Consideration to be paid for Notes that are validly tendered and not validly withdrawn at or prior to the Expiration Time has been increased to $1,155.00 for each $1,000 in principal amount of Notes, plus accrued and unpaid interest to, but not including, the settlement date. The Total Consideration, as amended, includes a consent payment of $30.00 for each $1,000 principal amount of the Notes to holders who validly tender and do not validly withdraw their Notes and provide their consents to the proposed amendments to the indenture governing the Notes at or prior to the Expiration Time.

Holders who have previously validly tendered Notes do not need to re-tender their Notes or take any other action in response to this amendment to be eligible to receive the increased Total Consideration.

Except for the amendment to the Total Consideration and the extension of the Consent Deadline as described above, the Offer to Purchase and the related Letter of Transmittal and Consent remain in full force and effect.

By 9 a.m. EST on the business day following the Expiration Time (the “Acceptance Date”), the Company will accept for payment any and all Notes validly tendered and not withdrawn prior to the Expiration Time, subject to the terms and conditions of the tender offer and the consent solicitation.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia